Johanna Friedl-Naderer
Chief Commercial Officer · 6 filings · Latest: Sep 4, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Sep 8, 2026 | Sale | $18.88 | 185 | $3.5K | 152,897 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Sep 4, 2026 | Sale | $24.35 | 900 | $21.9K | 153,082 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Aug 13, 2026 | Sale | $26.28 | 226 | $5.9K | 153,982 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Jun 16, 2026 | Sale | $18.33 | 145 | $2.7K | 154,208 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | May 13, 2026 | Sale | $18.36 | 228 | $4.2K | 154,353 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Mar 5, 2026 | Sale | $14.90 | 148 | $2.2K | 154,581 |